VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
RYAN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
RYANRyan Specialty Holdings, Inc.
$43.68$12.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRYANCash Flow

Ryan Specialty Holdings, Inc. (RYAN) Cash Flow Statement

7Y historyFree accessUpdated daily

Operating cash flow swung from -$167.4M in 2026Q1 to $293.0M in 2026Q2, but claims payouts surged 13-fold to $957.4M, and shareholder returns of $277.1M nearly matched OCF, indicating potential liquidity strain.

Income StatementBalance SheetCash FlowRatios

RYAN Cash Flow Statement

Annual statement

RYAN Cash Flow Statement

Ryan Specialty Holdings, Inc. (RYAN) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Cash from Operations558.52M643.67M514.87M477.2M335.51M273.49M135.39M149.51M
Operating CF Growth %35.13%25.02%7.89%42.23%22.68%102%-9.44%-
Operating CF / Revenue %17.36%21.1%20.47%22.97%19.45%19.09%13.3%19.54%
Net Income188.04M214.16M229.91M194.48M163.26M56.63M70.51M63.06M
Depreciation & Amortization285.26M287.51M167.63M115.84M109.29M112.68M67.5M53.1M
Stock-Based Compensation48.01M38.78M79M69.74M77.48M67.53M10.8M8.15M
Deferred Taxes38.2M26.05M24.22M36.66M14.54M-1.15M203K-800K
Other Non-Cash Items-187.42M114.45M43.49M22.59M45.94M67.23M27.89M5.56M
Working Capital Changes131.66M-37.28M-29.38M37.9M-74.99M-29.44M-41.51M20.44M
Cash from Investing-247.02M-834.01M-1.76B-476.23M-22.42M-457.94M-768.51M-148M
Capital Expenditures-61.84M-67.95M-47M-29.78M-15.04M-9.78M-12.5M-7.99M
Acquisitions-181.28M-746.49M-1.71B-446.68M0-108.88M-741.46M-144.4M
Purchase of Investments0-16.56M000000
Sale/Maturity of Investments00000000
Other Investing-3.91M-3.01M0228K-7.38M-339.27M-14.55M4.39M
Cash from Financing-66M78.12M1.17B-12.61M314.76M429.28M1.13B62.27M
Dividends Paid-65.57M-62.34M-80.24M-71.67M-39.88M-47.1M-50.12M-72.29M
Share Repurchases-303.75M-3.73M-27.46M-8.79M-7.17M-967.85M-52.56M-3.17M
Stock Issued000001.45B00
Debt Issuance (Net)-1000K1000K1000K-1000K1000K-1000K1000K1000K
Other Financing-69.75M89.79M-37.55M12.68M-15.66M92.12M176.2M58.91M
Net Change in Cash244.12M-96.33M-75.53M-11.05M627.72M243.96M493.54M64.05M
Exchange Rate Effect-1.38M15.89M-1.51M584K-126K-883K1.35M265K
Cash at Beginning1.48B1.68B1.76B1.77B1.14B895.7M402.16M338.11M
Cash at End1.76B1.58B1.68B1.76B1.77B1.14B895.7M402.16M
Free Cash Flow496.69M575.71M467.87M447.43M320.47M263.71M122.89M141.52M
FCF Growth %-2.69%23.05%4.57%39.62%21.52%114.58%-13.16%-
FCF Margin %15.44%18.87%18.6%21.54%18.58%18.41%12.07%18.5%
FCF per Share-2.071.73.561.212.491.151.33

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Volatile loss ratio and reserve adequacy

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Underwriting Cash Flow Swings Sharply

Ryan Specialty's operating cash flow swung from -$167.4M in 2026Q1 to $293.0M in 2026Q2, reflecting a $957.4M claims payout in Q2, as per recent SEC filings.

The dramatic quarter-over-quarter swing in operating cash flow underscores the inherent volatility in specialty underwriting. The $957.4M claims payment in 2026Q2, following a modest $69.4M in Q1, suggests a large loss event or adverse development that may strain liquidity. Despite this, the company generated positive OCF in most quarters, indicating that premium collections generally outpace claims payments, but the magnitude of swings warrants close monitoring.

Claims Payments Spike in Q2 2026

Claims paid surged to $957.4M in 2026Q2 from $69.4M in Q1, a 13-fold increase, as reported in the cash flow statement, signaling potential reserve strain.

The spike in claims payments aligns with the prior income statement analysis showing a loss ratio of 104.4% in 2026Q2, indicating underwriting losses. This suggests that the company may have experienced a significant catastrophe or adverse development, and the cash outflow may not be fully covered by operating cash flow in that quarter. Investors should assess whether this is a one-off event or a trend, as it directly impacts float and investment capacity.

Earnings Quality Questioned by Cash Flow Divergence

In 2026Q2, net income of $108.4M was accompanied by OCF of $293.0M, but the $957.4M claims payout suggests non-cash accruals may be masking underwriting losses, per the cash flow statement.

The divergence between net income and operating cash flow, particularly in quarters with high claims, indicates that reported earnings may not fully reflect cash realities. For instance, 2026Q1 showed a net loss of $27.6M but OCF of -$167.4M, implying that accruals for future claims or reserve releases are influencing reported profitability. This warrants scrutiny of reserve adequacy and the sustainability of earnings.

Buybacks and Dividends Outpace Cash Generation

Ryan Specialty returned $277.1M to shareholders in 2026Q2 via buybacks and dividends, exceeding the quarter's OCF of $293.0M, as per the cash flow statement.

The aggressive capital return, particularly the $260.2M buyback in 2026Q2, appears to be funded by operating cash flow and possibly existing cash reserves. While the company generated positive OCF in most quarters, the sustainability of such returns is questionable given the volatility in claims payments. If claims remain elevated, the company may need to reduce distributions or rely on portfolio liquidation, which could impact investment income.

What the Cash Flow Statement Obscures

The cash flow statement shows no investment purchases or sales, yet the company's float likely generates investment income; this omission may obscure the true cash generation, based on reported data.

The absence of investment portfolio activity in the cash flow data is notable for an insurance carrier. It may indicate that investment income is minimal or that the data is incomplete. However, the lack of purchases or sales suggests that the company is not actively managing its portfolio, which could limit yield enhancement. Additionally, the high claims payout in 2026Q2 may signal reinsurance recoverables that are not reflected in the cash flow, posing credit risk if reinsurers fail to pay.

RYAN — Frequently Asked Questions

Quick answers to the most common questions about buying RYAN stock.

How much cash does Ryan Specialty Holdings, Inc. (RYAN) generate from operations?

Ryan Specialty Holdings, Inc. (RYAN) generated $643.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Ryan Specialty Holdings, Inc.'s free cash flow?

Ryan Specialty Holdings, Inc. (RYAN) generated $575.7M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Ryan Specialty Holdings, Inc.'s capital expenditure (CapEx)?

Ryan Specialty Holdings, Inc. (RYAN) spent $68.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Ryan Specialty Holdings, Inc. distribute cash to shareholders?

In 2025, Ryan Specialty Holdings, Inc. (RYAN) returned $62.3M to shareholders via cash dividends and spent $3.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.